← Back
A

$ Value

$0

Shares

2,441

Price

$0

Filed

May 19

Insider

Name

Greco Theresa

Title

Chief Commercial Officer

CIK

0001998771

Roles

Officer

Transaction Details

Transaction Date

2025-05-15

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

53,314

Footnotes

Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest on May 15, 2026, which is the anniversary of the date of the grant. | Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on May 15, 2026, which is the first anniversary of the date of the grant. | The stock option vests in three equal annual installments beginning May 15, 2026, the first anniversary of the grant date.

Filing Info

Accession No.

0001628280-25-026500

Form Type

4

Issuer CIK

0001448431

Greco Theresa's History

Date Ticker Type Value
2025-12-23 OPRX F $18K
2025-11-01 OPRX F $35K
2025-08-21 OPRX A $0
2025-08-21 OPRX A $0
2025-05-15 OPRX A $0
2025-05-15 OPRX A $0
2025-05-15 OPRX A $0

Other Insiders at OPRX (90d)

No other insider activity at this issuer in the last 90 days.